Kodein Extractumpharma

Codeine phosphate hemihydrate, the active ingredient in Kodein Extractumpharma, is an opioid analgesic presented as an oral dosage form for oral use. It is employed to relieve mild to moderate pain and to suppress cough in adult patients.

GNH USA supplies Kodein Extractumpharma as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU quality standards and serving hospitals, pharmacies, transplant centres and clinics worldwide. Our global logistics network ensures timely delivery and regulatory documentation for each market, including customs clearance and temperature‑controlled handling where required.

Codeine phosphate hemihydrate is an opioid analgesic used in the management of pain and cough.

- Mild to moderate pain: provides analgesia to reduce discomfort in acute or chronic settings. - Cough: suppresses the cough reflex in non‑productive coughs, improving patient comfort. - Post‑operative pain: helps control pain after minor surgical procedures. - Dental pain: alleviates pain associated with dental extractions or procedures.

Codeine phosphate hemihydrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Nausea: feeling of stomach upset or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Dry mouth: reduced salivary flow leading to a parched sensation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing, potentially life‑threatening. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Hypotension: unusually low blood pressure causing dizziness or fainting.

When prescribing or dispensing Codeine phosphate hemihydrate, consider the following safety measures.

- Pain assessment: evaluate the severity and cause of pain before initiating therapy. - Respiratory monitoring: observe for signs of respiratory depression, especially in opioid‑naïve patients. - CNS depressant use: avoid concurrent use with alcohol, benzodiazepines, or other sedatives. - Hepatic impairment: use with caution in patients with liver dysfunction, adjusting dose as needed. - Dependence risk: limit duration of use and monitor for signs of misuse or addiction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Codeine phosphate hemihydrate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, alcohol): may intensify sedation and respiratory depression. - MAO inhibitors: can precipitate severe hypotension or serotonin syndrome. - Opioid antagonists (e.g., naloxone): may reverse analgesic effects abruptly.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may reduce conversion of codeine to its active metabolite, decreasing analgesia. - Antihistamines: can increase drowsiness. - Diuretics: may enhance the risk of hypotension.